Novartis Reorganizes Its US Pharma Unit, Replacing CEO And Slashing 250 Jobs
The drug maker creates four business units, including primary care, which remains "critically important" to future growth.
The drug maker creates four business units, including primary care, which remains "critically important" to future growth.